NCT03629600View on ClinicalTrials.gov

Trial of Aggressive Hydration Versus Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

October 15, 2017

Primary Completion Date

February 15, 2018

Study Completion Date

May 31, 2018

Conditions
Post-ERCP Acute Pancreatitis
Interventions
DRUG

Lactated Ringer

High-volume Lactated Ringer Solution

DRUG

Rectal Form Indometacin

Post-ERCP rectal administration of 100 MG Indomethacin

Trial Locations (1)

700020

IPGIMER, Kolkata

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT03629600 - Trial of Aggressive Hydration Versus Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis | Biotech Hunter | Biotech Hunter